Market status · September 2026
BPC-157.
The retreat.
The most searched research peptide is quietly disappearing from consumer storefronts. This page tracks what that means and what still carries a public price.
What happened
Through 2026, AgelessRx, Eden, Hone, Fridays, Joi and Blokes, Strut, Maximus, Defy, Invigor and Regenics either removed BPC-157, moved it to waitlists or hid it behind memberships — zero public prices remain among the consumer brands that publish prices for everything else. That is the market reading the FDA compounding-risk flag in real time, and it is itself the most useful price signal on this page.
Who still shows a price
Why nothing is ranked here
BPC-157 has no approved form, no human trials and an FDA compounding-risk flag — comparing sellers on price would imply a purchase this site does not endorse. The numbers above exist so nobody overpays out of ignorance; the evidence page exists so nobody pays at all without reading it.
Read the BPC-157 evidence first